Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Operable Head and Neck Squamous Cell Carcinoma
NCT02402348Phase 1Terminated
- Sponsor
- West Virginia University
- Start
- Dec 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of metformin in head and neck squamous cell carcinoma (HNSCC), sponsored by West Virginia University. Primary endpoint: Tumor cell death estimated by percentage at 30 days. Started Dec 2014; status: terminated.
02
Drugs
metformin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02402348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402348.